Accelerate Your Journey from Clinic to Market

Image © Agilent Technologies, Inc. 2024 Sponsored by Driving the Field of Oligonucleotide Therapeutics State-of-the-Art Solutions for Oligonucleotide Characterization, Purification, and Manufacturing / Chapter 1: Introduction to Oligonucleotide Therapeutics / Chapter 2: Challenges for Oligonucleotide Synthesis and Production / Chapter…

Agilent AdvanceBio Oligonucleotide Columns and Oligonucleotide Standards IMPROVE RELIABILITY. REDUCE COSTS. INCREASE FLEXIBILITY. AGILENT ADVANCEBIO OLIGONUCLEOTIDE COLUMNS AND OLIGONUCLEOTIDE STANDARDS HIGH-RESOLUTION OLIGONUCLEOTIDE SEPARATIONS WITH LONG COLUMN LIFETIME ON HPLC AND UHPLC SYSTEMS Synthetic oligonucleotides are promising therapeutic agents for the…

Application Note CRISPR Single Guide RNA Characterization by IP- RP-LC-MS with a Premier Oligonucleotide BEH 300 Å C18 Column Maissa M. Gaye, Chris Knowles, Balasubrahmanyam Addepalli, Matthew A. Lauber Waters Corporation Abstract The high speed, low cost, and reduced need…

Agilent Case Study Interview: Evaluating an Innovative Analytical ID Testing Strategy for Oligonucleotides Tell us about your company. Vetter is a family-owned contract development and manufacturing organization (CDMO) headquartered in Ravensburg, Germany, with production facilities in Germany, Austria, and the…